Maura L Gillison MD, PhD


​ 

Maura L Gillison MD, PhD
ProfessorCollege of Medicinegillison.3@osu.edu
690 Tzagournis Med Res Facility 420 W 12th Avenue Columbus Ohio 43210
Phone:614-247-4589Fax: 614-688-4245
  • Cancer Control
  • Viral Oncology

General Research Interest

Head and neck cancer, human papillomavirus, infectious-disease tumor associations

Research Description

The principal focus of the Gillison laboratory is to investigate the role of human papillomavirus infection in head and neck malignancies, from cohort studies of oral HPV infection to genetic indicators of response to chemoradiotherapy.

Transinstitutional Work

The Gillison laboratory has several ongoing collaborations with the Centers for Disease Control, USA, the National Cancer Institute, USA, and the International Agency for Research on Cancer. Dr. Gillison is also a member of the head and neck steering committees of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Current Publications

  • Wells SIDEK promotes HPV-positive and -negative head and neck cancer cell proliferation.Oncogene 0 1 3/10/2014
  • Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison MLGenome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res 24 185-99 2/1/2014
  • Unger ERPrevalence of Cervical and Oral Human Papillomavirus Infections Among US Women.J Infect Dis 1/10/2014
  • Sanjosé SdComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 7 H1-31 12/31/2013
  • Sanjosé SdComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 6 G1-31 12/30/2013
  • Sanjosé SdComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 5 F1-31 12/29/2013
  • Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison MLWorldwide trends in incidence rates for oral cavity and oropharyngeal cancers.J Clin Oncol 31 4550-9 12/20/2013
  • Sanjosé SdComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 8 I1-31 11/22/2013
  • Perez-Ordoñez B, Irish JC, Yu ES, Gillison MLHuman papillomavirus-16 associated adenocarcinoma NOS of base of tongue.Head Neck Pathol 7(3) 268-73 9/1/2013
  • Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes MHead and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.J Natl Compr Canc Netw 11(8) 917-23 8/1/2013
  • Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison MLNatural history of anal vs oral HPV infection in HIV-infected men and women.J Infect Dis 208(2) 330-9 7/15/2013
  • Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi SEurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.Int J Cancer 134(3) 497-507 2/1/2013
  • Lingen MW, Xiao W, Schmidt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison MLLow etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.Oral Oncol 49(1) 1-8 1/1/2013
  • Schwartz S, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, , Castellsagué XHuman papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.Vaccine 30 Suppl 5 F34-54 11/20/2012
  • Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Kovacic MB, Wikenheiser-Brokamp KA, Wells SIThe fanconi anemia pathway limits human papillomavirus replication.J Virol 86(15) 8131-8 8/1/2012
  • Pickard RK, Xiao W, Broutian TR, He X, Gillison MLThe prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years.Sex Transm Dis 39(7) 559-66 7/1/2012
  • Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison MLValidation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.Am J Surg Pathol 36(7) 945-54 7/1/2012
  • Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KKTobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.J Clin Oncol 30(17) 2102-11 6/10/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu